LDV Capital
  • Home
  • Portfolio
  • Vision Events
  • Insights
  • News
  • Community
  • Blog
  • About
LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
LDV Capital

LDV Blog

LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
November 01, 2024

Drug Discoverer Shares Opportunities in Therapeutics & AI

November 01, 2024/ Kat Lopez
Drug Discoverer Shares Opportunities in Therapeutics & AI

Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in ​​life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.

Read More
November 01, 2024/ Kat Lopez/
Biotech & Life Sciences
Investment Trends, Life Sciences, Biotech, Dr. David Rabuka, serial biotech entrepreneur, investor, clinical therapies, Redwood Biosciences, Carolyn Bertozzi, Catalent Pharma Solutions, LDV Capital, visual technology, artificial intelligence, AI, healthcare, Dr. Laura Smoliar, LDV experts, Annual General Meeting, therapeutics, personalized medicine, biotech industry, genetic makeup, medical treatments, supply chain, GLP-1, weight loss drugs, anti-cancer drugs, antibody-drug conjugates, chemotherapy, radioisotope therapies, Zevalin, Bexxar, radioactive materials, small-molecule therapies, biologics, antibodies, barbell drugs, synthetic macromolecules, PROTACs, new therapeutic modalities, mRNA, Large datasets

Stay In The Know

From New Materials to Biotech, Neuroscience and More: Your Monthly Dispatch on All Things Visual Tech & AI

Thank you!

©LDV Capital